Rani Therapeutics names Michelle Gilson to board as audit committee chair
RANI•Board appointment
Rani Therapeutics named Michelle Gilson to its board, appointing her audit committee chair.
Gilson was most recently CFO of Arcellx, acquired by Gilead in 2026.
Her earlier career included biotechnology equity research roles at major investment banks.
